Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 733 1.09%
22 Nov - close price
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 8,056 Cr.
  • Current Price ₹ 733
  • High / Low ₹ 1,107 / 673
  • Stock P/E 136
  • Book Value ₹ 250
  • Dividend Yield 0.17 %
  • ROCE 7.39 %
  • ROE 4.54 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 2.93 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 6.99% over last 3 years.
  • Company has high debtors of 176 days.
  • Promoter holding has decreased over last 3 years: -4.17%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE 250 SmallCap Index BSE Allcap BSE Commodities BSE 400 MidSmallCap Index BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
249 266 325 310 314 296 371 288 317 215 308 164 191
185 191 220 213 219 206 279 210 226 151 235 127 139
Operating Profit 63 75 105 97 95 89 92 78 91 64 74 37 52
OPM % 25% 28% 32% 31% 30% 30% 25% 27% 29% 30% 24% 22% 27%
6 5 -8 -13 -5 -4 18 10 4 1 11 6 4
Interest 5 5 14 12 16 14 20 18 20 25 25 22 25
Depreciation 15 16 15 16 16 17 17 17 18 18 18 19 20
Profit before tax 50 60 67 57 58 54 74 54 57 22 42 2 11
Tax % 28% 36% 33% 34% 29% 29% 30% 35% 32% 29% 32% 30% -29%
36 38 45 37 41 39 51 35 39 15 28 1 14
EPS in Rs 3.59 3.79 4.50 3.73 4.11 3.61 4.77 3.24 3.60 1.40 2.58 0.13 1.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
107 228 273 288 288 343 502 529 811 1,074 1,284 1,129 878
86 179 204 208 218 269 408 394 618 770 917 822 651
Operating Profit 21 49 69 80 70 73 93 134 193 304 367 307 227
OPM % 19% 22% 25% 28% 24% 21% 19% 25% 24% 28% 29% 27% 26%
0 2 5 8 11 6 19 11 26 7 2 26 22
Interest 8 22 14 21 21 15 24 45 69 31 62 87 97
Depreciation 3 5 10 13 15 18 23 29 52 60 66 72 75
Profit before tax 10 24 50 54 45 48 66 71 99 220 242 174 76
Tax % 30% 23% 28% 21% 22% 19% 24% 26% 30% 32% 30% 32%
7 18 36 43 35 39 50 53 70 151 169 117 59
EPS in Rs 7.29 18.45 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.69 10.69 5.39
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 7% 7% 16% 12%
Compounded Sales Growth
10 Years: 17%
5 Years: 18%
3 Years: 12%
TTM: -31%
Compounded Profit Growth
10 Years: 20%
5 Years: 18%
3 Years: 17%
TTM: -64%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -3%
1 Year: -23%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 7%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 10 10 50 50 50 50 50 50 100 100 107 110 110
Reserves 23 61 58 97 194 382 432 515 1,473 1,624 2,252 2,534 2,636
56 117 144 279 318 449 687 846 423 836 822 1,067 1,287
20 29 51 55 70 97 145 252 300 325 388 640 586
Total Liabilities 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,618
45 90 145 259 313 379 682 978 1,116 1,203 1,240 1,277 1,794
CWIP 1 1 21 64 88 250 183 101 42 43 113 579 184
Investments 1 0 2 2 2 2 0 0 0 148 158 159 159
61 126 134 157 230 347 449 583 1,137 1,492 2,057 2,336 2,481
Total Assets 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,618

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
10 51 68 69 17 -8 42 95 1 -171 244 22
-8 -38 -88 -168 -93 -247 -261 -178 -192 -412 -478 -362
-1 11 9 100 73 254 209 102 416 384 376 398
Net Cash Flow 0 24 -10 0 -3 -0 -9 19 224 -199 142 58

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 45 48 36 28 71 94 88 89 92 95 106 176
Inventory Days 252 153 158 211 305 411 277 513 528 849 626 849
Days Payable 81 56 92 94 156 148 105 225 213 223 202 332
Cash Conversion Cycle 216 144 101 144 220 358 260 378 407 721 530 692
Working Capital Days 151 120 86 113 152 207 167 184 232 327 302 431
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11% 7%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
65.40% 65.18% 65.17% 65.16% 60.96% 60.80% 60.77% 60.73% 61.41% 61.26% 61.23% 61.23%
5.73% 5.73% 4.98% 4.59% 8.19% 8.52% 9.79% 10.26% 9.13% 8.07% 7.14% 7.00%
3.75% 3.68% 4.40% 4.40% 6.18% 4.98% 3.74% 1.76% 2.51% 2.56% 2.56% 2.30%
25.12% 25.41% 25.45% 25.84% 24.67% 25.68% 25.71% 27.25% 26.96% 28.10% 29.06% 29.47%
No. of Shareholders 60,62965,07165,87071,49273,32666,50761,50461,12960,08957,62362,21863,866

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls